Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.251EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.251EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.251ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.251ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.251EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.251EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.251ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.251ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCJEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCJECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCJECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCJEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCJEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCJENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FT.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FT.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FT.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FT.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FZ.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FZ.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FZ.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FZ.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.497EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.497EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used